However, although there are evidence showing the role of posttranscriptional regulatory mechanisms implicated in the pathology of AD, especially by miRNAs, many of these studies had been mainly focused on the modulation of key AD-associated genes such as APP, PS1, etc. [210]. This evidence concerns the gene APP and Alzheimer disease.